Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Provectus Biopharmaceuticals, Inc. (PVCT) had Return on Investments of 21.55% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-1.31M |
|
-- |
|
-- |
|
$1.28M |
|
$-1.28M |
|
$-0.05M |
|
$-1.32M |
|
$-1.32M |
|
$-1.32M |
|
$-1.32M |
|
$-1.32M |
|
$-1.32M |
|
$-1.28M |
|
$-1.28M |
|
420.28M |
|
420.28M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.28M |
|
$0.00M |
|
$0.14M |
|
$0.42M |
|
$6.47M |
|
$0.02M |
|
$0.12M |
|
$6.59M |
|
$-6.18M |
|
$-6.17M |
|
$-6.17M |
|
420.28M |
|
| Cash Flow Statement Financials | |
$-2.46M |
|
-- |
|
$2.04M |
|
$0.49M |
|
$0.07M |
|
$-0.42M |
|
$0.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.04 |
|
-- |
|
-- |
|
-0.00 |
|
-0.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.46M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
21.41% |
|
21.46% |
|
-315.22% |
|
|
Return on Investments |
21.55% |
$-0.01 |
|
$-0.01 |
|
$-0.01 |
|